Nautilus Biotechnology Regains Nasdaq Compliance After Transfer to Capital Market
Nautilus Biotechnology Inc. has regained compliance with Nasdaq's minimum bid price requirement after transferring to the Nasdaq Capital Market. The company received notice on November 3, 2025, confirming its closing bid price met or exceeded $1.00 for at least ten consecutive business days. Consequently, Nautilus remains listed on The Nasdaq Capital Market, closing the matter regarding its previous non-compliance.
Nautilus Biotechnology Inc. has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. After previously transferring from the Nasdaq Global Select Market due to its stock trading below $1.00 for an extended period earlier this year, the company received notice on November 3, 2025, that its closing bid price met or exceeded $1.00 for at least ten consecutive business days. As a result, the matter is now closed, and Nautilus remains listed on The Nasdaq Capital Market. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nautilus Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001808805-25-000082), on November 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
